Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Fractyl Health on the transaction, and Goodwin Procter advised the underwriters. Fractyl Health (Nasdaq: GUTS) announced the...
Fractyl Health’s $110 Million Initial Public Offering
Fractyl Health’s $100 Million Series F Financing
Latham & Watkins LLP represented Fractyl Health in the transaction. Fractyl Health, a life sciences company dedicated to developing novel therapeutic interventions aimed at reversing the...